The Zhitong Finance App learned that Hunterbrook Media (Hunterbrook Media) said that Hims & Hers Health (HIMS.US) will be the main beneficiary of President-elect Donald Trump's nomination of Marty Makary (Marty Makary) as Director of the US Food and Drug Administration (FDA). The company's stock price then rose 24% to $31.35, closing at a record high.

Zhitongcaijing · 11/26 02:09
The Zhitong Finance App learned that Hunterbrook Media (Hunterbrook Media) said that Hims & Hers Health (HIMS.US) will be the main beneficiary of President-elect Donald Trump's nomination of Marty Makary (Marty Makary) as Director of the US Food and Drug Administration (FDA). The company's stock price then rose 24% to $31.35, closing at a record high.